risk-adapted therapy: three-day versus five-day oral decitabine in patients with mds
Published 2 months ago • 38 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
0:21
3-d ihc: mouse kidney - cd31, tubulin beta 3 (tubb3), podoplanin
-
2:03
discover the reliability of mindray 3-part hematology analyzer
-
1:13
03pm anisidina su grassi merendine eng
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
0:27
3-d ihc: mouse kidney - cd326 (ep-cam), tubulin beta 3 (tubb3), podoplanin
-
0:13
omnitest 3 control solution 2 x 3 5ml 9332768g
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
![magnetic irgd mbs umi - supplementary video 3 [id 359065]](https://i.ytimg.com/vi/L2JMu1RLack/mqdefault.jpg)
0:16
magnetic irgd mbs umi - supplementary video 3 [id 359065]
-
0:50
3d-immunofluorescence of human cerebral organoid stained with ki-67, β-tubulin 3 and sox2 antibodies
-
0:40
haemostatic techniques with dr remedios
-
1:23
model 3 core board empowers efficient hmi (human machine interface) solution
-
2:14
3d mammography now offered at dmg!
-
0:40
ck3
-
0:50
nd2o3 nps induce toxicity and cardiac/cerebrovascular abnormality- supplementary video 9 id 220785
-
1:26
nd2o3 nps induce toxicity and cardiac/cerebrovascular abnormality- supplementary video 4 id 220785
-
1:52
philips monitors with masimo o3 reginal oximetry system
-
1:28
module 3 - complex cases - sample 2
-
4:17
using your trk-3 omnia in manual mode
-
1:13:17
2d to 3d ebrt | session 16 | evaluating normal tissue constraints and plans for treatment